trending Market Intelligence /marketintelligence/en/news-insights/trending/MoEXXoS2FbAqZo0MUNsk3g2 content esgSubNav
In This List

Matinas BioPharma appoints director

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Matinas BioPharma appoints director

Matinas BioPharma Holdings Inc. appointed Matthew Wikler to its board, replacing current member Stefano Ferrari, effective Jan. 1, 2018.

Wikler currently serves as the principal of Infectious Disease Technology Development Consulting.